MIAMI BEACH, FLA.—Two presentations at TCT 2012 demonstrated that use of the Watchman device for left atrial appendage (LAA) closure in patients contraindicated for warfarin is safe and feasible. The ...
TipRanks on MSN
Boston Scientific’s WATCHMAN FLX Pro registry: A new frontier in atrial fibrillation treatment
Boston Scientific (BSX) announced an update on their ongoing clinical study.Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools ...
BATON ROUGE, LA (WAFB) - Cardiologists at Baton Rouge General performed a first of it’s kind, heart implant surgery in Baton Rouge on Thursday. The Watchman is for a specific patient with atrial ...
Carol Harman was tired of the frequent blood tests required during the conventional drug treatment for her heart condition. So, when her doctors at Moffitt Heart and Vascular Group announced a study ...
Fe Almo enjoys "taking it easy" by going to dinners, gardening and venturing on occasional cruise vacations. But for two years, a life-threatening heart condition prevented the retiree from an active ...
Percutaneous closure of the left atrial appendage (LAA) with the Watchman device can be safely performed without a warfarin transition, and is a reasonable alternative for patients with atrial ...
Back in March, we reported about a new state-of-the-art medical procedure being done for the first time at Christus Spohn Shoreline Hospital. The three patients who underwent that surgical procedure ...
MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning ...
A new device offers a new option to people with a certain heart condition that puts them at risk for strokes, but who can't take the risks of blood-thinning medications. Sandy Snovelle had a few other ...
Patients with atrial fibrillation, or AFib, are at increased risk for stroke.Many of them go on blood thinners, which can cause problems. But there is a relatively new device that is being used ...
Encouraging long-term results from the PROTECT AF trial comparing the Watchman left atrial appendage closure device to warfarin in atrial fibrillation patients were presented yesterday at the Heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback